5-134115370-C-A

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2

The NM_003202.5(TCF7):​c.299C>A​(p.Pro100Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000218 in 1,602,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000022 ( 0 hom. )

Consequence

TCF7
NM_003202.5 missense

Scores

1
4
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.52
Variant links:
Genes affected
TCF7 (HGNC:11639): (transcription factor 7) This gene encodes a member of the T-cell factor/lymphoid enhancer-binding factor family of high mobility group (HMG) box transcriptional activators. This gene is expressed predominantly in T-cells and plays a critical role in natural killer cell and innate lymphoid cell development. The encoded protein forms a complex with beta-catenin and activates transcription through a Wnt/beta-catenin signaling pathway. Mice with a knockout of this gene are viable and fertile, but display a block in T-lymphocyte differentiation. Alternative splicing results in multiple transcript variants. Naturally-occurring isoforms lacking the N-terminal beta-catenin interaction domain may act as dominant negative regulators of Wnt signaling. [provided by RefSeq, Oct 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.40168923).
BS2
High AC in GnomAdExome4 at 32 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TCF7NM_003202.5 linkc.299C>A p.Pro100Gln missense_variant 2/10 ENST00000342854.10 NP_003193.2 P36402-5B3KQ75

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TCF7ENST00000342854.10 linkc.299C>A p.Pro100Gln missense_variant 2/101 NM_003202.5 ENSP00000340347.5 P36402-5
TCF7ENST00000395029.5 linkc.299C>A p.Pro100Gln missense_variant 2/115 ENSP00000378472.1 B7WNT5
TCF7ENST00000518887 linkc.-47C>A 5_prime_UTR_variant 1/52 ENSP00000430617.1 E5RJ51
TCF7ENST00000522653.5 linkn.19C>A non_coding_transcript_exon_variant 1/82

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152136
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000221
AC:
32
AN:
1450778
Hom.:
0
Cov.:
32
AF XY:
0.0000208
AC XY:
15
AN XY:
720712
show subpopulations
Gnomad4 AFR exome
AF:
0.0000302
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000237
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000244
Gnomad4 OTH exome
AF:
0.0000334
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152136
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74338
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000416
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 24, 2023The c.299C>A (p.P100Q) alteration is located in exon 2 (coding exon 2) of the TCF7 gene. This alteration results from a C to A substitution at nucleotide position 299, causing the proline (P) at amino acid position 100 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.022
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
19
DANN
Benign
0.94
DEOGEN2
Benign
0.27
.;T
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.70
T;T
M_CAP
Pathogenic
0.88
D
MetaRNN
Benign
0.40
T;T
MetaSVM
Uncertain
0.59
D
MutationAssessor
Benign
-0.46
N;.
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-0.58
N;N
REVEL
Uncertain
0.35
Sift
Benign
0.37
T;T
Sift4G
Benign
0.19
T;T
Polyphen
0.0010
B;.
Vest4
0.39
MutPred
0.42
Loss of glycosylation at P100 (P = 0.0617);Loss of glycosylation at P100 (P = 0.0617);
MVP
0.91
MPC
0.19
ClinPred
0.15
T
GERP RS
1.6
gMVP
0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs762174577; hg19: chr5-133451061; API